Martin Schlumberger

Martin Schlumberger is a leading oncologist and Professor of Clinical Medicine at Université Paris-Saclay, with a 40-year career dedicated to thyroid cancer research and treatment. He is affiliated with Gustave Roussy, where he has integrated clinical practice and research, and contributed to establishing multidisciplinary thyroid cancer centers in Italy as an Associate Professor at Sapienza University in Rome.

• Key roles: Oncologist at Gustave Roussy, Professor at Université Paris-Saclay, Associate Professor at Sapienza University in Rome
• Research focus: Genomic signatures in thyroid cancer, tyrosine kinase inhibitors, radiobiology, medical-economic analyses, and patient quality-of-life assessments

Scientific Contributions:

• Developed the first thyroglobulin trial in Europe during his thesis
• Advanced genomic differentiation between radiation-induced and spontaneous thyroid cancers through collaborations with CEA-INSTN
• Championed active monitoring for small thyroid tumors, reducing aggressive treatments
• Co-developed tyrosine kinase inhibitors combined with immunotherapy for advanced thyroid cancers

Awards & Recognition:

• Academy of Medicine award (France)
• Academy of Science award (France)
• WHO reference center designation for thyroid radiobiology in 1997
• National Expert Centre for Refractory Thyroid Cancers in 2009

Leadership & Teaching:

• Founded the Gustave Roussy School of Cancer Sciences
• Chaired the EORTC Endocrine Tumour Group
• Directed Université Paris-Saclay's Doctoral School of Oncology
• Co-authored over 350 original articles and two books